Genetic screening and ethical issues
Studying this course? Keep your progress in one place.
Key facts
- Genetic screening tests for particular alleles or chromosome abnormalities; it gives information but does not treat a disorder.
- If both parents are carriers, each child has a 1 in 4 chance of the disorder and a 1 in 2 chance of being a carrier.
- PGD tests embryos made by IVF at the eight-cell stage before they are implanted.
- Amniocentesis (from about 15 weeks) and CVS (from about 11 weeks) test the fetus and carry a miscarriage risk of roughly 1%.
- Ethical arguments include sanctity of life, utilitarian, autonomy, disability rights and the slippery slope.
What is genetic screening?
Genetic screening tests people, embryos or fetuses for a particular allele or chromosome abnormality.
Genetic screening is testing for the presence of a particular allele or chromosome abnormality. DNA is usually extracted from a blood sample, cheek swab, or cells from an embryo or fetus, and tested for the allele.
It gives information about alleles or chromosomes; it does not treat or cure a disorder.
- 1
Carrier screening
adults, before having children
- 2
PGD
embryos made by IVF, before placing in the uterus
- 3
Prenatal testing
the fetus, during pregnancy
| Carrier screening | PGD | Prenatal testing | |
|---|---|---|---|
| Who or what is tested | Adults | Embryos made by IVF | Fetus |
| When | Before having children | Before the embryo is placed in the uterus | During pregnancy |
Carrier screening
- Who or what is tested:
- Adults
- When:
- Before having children
PGD
- Who or what is tested:
- Embryos made by IVF
- When:
- Before the embryo is placed in the uterus
Prenatal testing
- Who or what is tested:
- Fetus
- When:
- During pregnancy
Which of these is a use of genetic screening?
Identifying carriers
Carrier screening shows whether a person could pass on a recessive allele; if both partners are carriers each child has a 1 in 4 chance of the disorder.
A carrier is a heterozygote with one copy of a recessive allele and no symptoms. Carrier screening, for example for the CF allele, shows whether a person could pass it on.
Genetic counselling explains the risks and the options: PGD, prenatal testing, adoption, or deciding not to have children.
| Homozygous recessive | Heterozygous | Homozygous dominant | |
|---|---|---|---|
| Chance for each child | 1 in 4 | 1 in 2 | 1 in 4 |
| Phenotype | Has the disorder | Carrier, no symptoms | Unaffected, not a carrier |
Homozygous recessive
- Chance for each child:
- 1 in 4
- Phenotype:
- Has the disorder
Heterozygous
- Chance for each child:
- 1 in 2
- Phenotype:
- Carrier, no symptoms
Homozygous dominant
- Chance for each child:
- 1 in 4
- Phenotype:
- Unaffected, not a carrier
Two parents are both carriers of cystic fibrosis. What is the chance that a child is a carrier but unaffected?
Pre-implantation genetic diagnosis (PGD)
PGD tests embryos made by IVF for a faulty allele, so only unaffected embryos are implanted.
PGD is used for couples with a known risk of passing on a serious genetic disorder.
Embryos are made by IVF. At the eight-cell stage, one or two cells are removed from each embryo. These cells are totipotent and unspecialised, so removing them does not stop the embryo developing.
- 1
IVF
eggs are fertilised outside the body to make embryos
- 2
Eight-cell stage
one or two cells are removed from each embryo
- 3
DNA test
the cells are tested for the faulty allele
- 4
Selection
only unaffected embryos are chosen
- 5
Implantation
chosen embryos are placed in the uterus
Advantages
- No pregnancy has to be terminated
Disadvantages
- IVF is expensive, involves hormone treatment and often fails
- Affected embryos are discarded
Why can cells be removed from an eight-cell embryo without stopping its development?
Prenatal testing
Amniocentesis tests amniotic fluid from about 15 weeks, and CVS tests placental tissue from about 11 weeks; both carry a miscarriage risk.
Amniocentesis: a needle passed through the abdomen takes amniotic fluid containing fetal cells, whose DNA or chromosomes are analysed.
Chorionic villus sampling (CVS): a sample of tissue from the chorion (placenta) is taken, using a needle or a tube through the cervix. The cells have the fetus's genotype.
Prenatal tests do not treat the disorder: they give information.
11 weeks
CVS from 11 weeks
Tissue from the chorion (placenta); miscarriage risk about 1%.
15 weeks
Amniocentesis from 15 wks
Amniotic fluid with fetal cells; miscarriage risk about 1%.
| Amniocentesis | CVS | |
|---|---|---|
| Timing | From about 15 weeks | From about 11 weeks |
| Sample | Amniotic fluid with fetal cells | Tissue from the chorion (placenta) |
| Risk | Miscarriage, roughly 1% | Miscarriage, roughly 1% |
Amniocentesis
- Timing:
- From about 15 weeks
- Sample:
- Amniotic fluid with fetal cells
- Risk:
- Miscarriage, roughly 1%
CVS
- Timing:
- From about 11 weeks
- Sample:
- Tissue from the chorion (placenta)
- Risk:
- Miscarriage, roughly 1%
What is the main advantage of CVS over amniocentesis?
Implications of prenatal screening
A positive result forces a difficult decision and a negative result gives reassurance but not certainty.
A positive result means the parents must decide whether to continue the pregnancy, which can cause great distress. A negative result gives reassurance, but no test is 100% accurate.
Other implications: waiting for results causes anxiety, the tests risk miscarriage, results may reveal unexpected information such as non-paternity, and parents might feel pressure toward termination or prepare early to care for a child with the condition.
- 1
Prenatal test result
- 2
Positive
parents decide whether to continue the pregnancy; great distress possible
- 3
Negative
reassurance, but no test is 100% accurate
Positive result
- Decision whether to continue the pregnancy
- Great distress possible
Negative result
- Reassurance
- But no test is 100% accurate
Give two implications of a prenatal test for the parents.
Try an exam question
Discuss the ethical issues raised by pre-implantation genetic diagnosis (PGD).
[4 marks]
- [1]Embryos with the faulty allele are discarded, which is wrong from a sanctity of life viewpoint.
- [1]It avoids having to terminate an established pregnancy.
- [1]A utilitarian view supports it because it reduces suffering.
- [1]It might be extended to non-medical traits (slippery slope), and cost may mean unequal access.
That's the notes covered.
Carry on to the next subtopic.
Try a question
What is the name of this type of genetic screening?
1 mark, marked against the mark scheme
What is the name of this type of genetic screening?
1 mark, marked against the mark scheme
Social and ethical issues
Name a viewpoint and apply it: sanctity of life, utilitarian, autonomy, disability rights, slippery slope and social issues.
Examiners expect you to name a viewpoint and apply it.
Sanctity of life (often religious): human life begins at fertilisation. Utilitarian: choose the action giving the greatest overall good. Autonomy: parents may make informed decisions about their own reproduction.
In discussion questions, give at least two different viewpoints, show how they disagree, then reach a justified conclusion if asked.
Name a viewpoint
sanctity of life, utilitarian, autonomy…
Apply it to the case
Give a second, different viewpoint
Show how they disagree
Reach a justified conclusion
if asked
Idea
Likely view
A couple argue that they have the right to choose which embryos are implanted. Which viewpoint is this?